Custom Search

Wednesday, October 13, 2010

Extended-Release Inectable dosage form of Naltrexone gets US FDA approval for treating patients with opioid-dependance

Extended-Release Inectable dosage form of Naltrexone gets US FDA approval for treating patients with opioid-dependance

The United States F D A has approved Inectable dosage form of naltrexone (Vivitrol) for treating patients having opioid dependence , for those who have undergone detoxification treatment to treat and prevent relapse of opoid dependence.
Vivitrol is an extended-release formulation containing naltrexone as an active ingredient It is an intramuscular injection which is administered once a month.



















Naltrexone is the N-cyclopropylmethyl derivative of oxymorphone.Naltrexone closely resemble to morphine molecule , in morphine molecule there is a methyl group over tertiary amine that is replaced with cyclopropylemethyl group, because of this Naltrexone has capability to reduce the addiction or dependence of morphine by occupying morphine/opoiod receptors. Naltrexone works by blocking opioid receptors in the brain. It blocks the effects of drugs like morphine, heroin, and other opioids.


In opoid dependence detoxification patients are required to take daily dose of oral dosage form of Naltrexone for 12 months to prevent relapse of opoid dependence, and there are chances that patient may skip his dose one or the other time which makes him prone for reoccurrence of opoid dependence. The Vivitrol (Naltrexone) an extended-release formulation which requires to be administred once in a month intramuscularly will be able to make free from daily schedule of oral dose, and can over come disadvantages of oral dosage form Naltrexone
In 2006 Vivitrol is also approved by US FDA to for treatment of alcohol dependence.
Clinical Trial
Safety and efficacy study for Vivitrol was done for six months, it was observed that patients on Vivitrol treatment who were completed detoxification were found to be no longer physically dependent on opioids compared to placebo . About 36 % of the patients treated with Vivitrol were able to stay away from illicit drugs for the full six months of study without using drugs, compared with 23 percent in the placebo group.
It is required that patients must be free from any presence of opioid drugs in their system when they start taking Vivitrol ; otherwise, it is likely to that they may show withdrawal symptoms from the opioids. At the time when next dose schedule for Vivitrol is due patients may become more sensitive to opioids as well. It is likely that patients when miss a dose or after treatment with Vivitrol has ended, patients can accidentally overdose if they restart opioid use.
Side effects: of Vivitrol. dizziness, vomiting, nausea, tiredness, headache , decreased appetite, painful joints, and muscle cramps.
Other serious side effects included reactions at the site of the injection, which can be severe and may require surgical intervention, liver damage, allergic reactions such as hives, rashes, swelling of the face, pneumonia, depressed mood, suicide, suicidal thoughts, and suicidal behavior.

Vivitrol must be administered by a physician as an intramuscular injection, a special administration needles are also provided with Vivitrol and it must not be injected using any other needle

Vivitrol is manufactured by Alkermes, Inc. a pharmaceutical company based in USA Waltham, Massachusetts. They are in to the business of developing and marketing extended release drugs so that the drugs remain in body over a prolonged and desired period of time period.

=====================================================================================================
Do you know now this website has become a most popular and most referred website in pharmaceutical industry and pharmaceutical companies and pharmaceutical manufacturers from all over the world ,for almost all topics related to Pharmaceutical Manufacturing , Pharmaceutical Regulatory Affairs and Good Manufacturing Practice for Pharmaceutical Manufacturing (c GMP guidelines ) and latest news and new drugs developments.

=====================================================================================================
You may also like following articles

Whar is Referance Listed Drug  ? ( RLD )

What is Pharmaceutical Equivalents

What is Pharmaceutical Alternatives

What is Therapeutic Equivalents


Do Physical properties contribute to drug activity.

What is drug receptor , How a drug resistance occurs

Mechanism of drug resistance

What is drug interaction

Drug interaction, and its examples

What is first pass metabolism of a drug

What is What is 510(k) Clearances ?

What is 510(k) Clearances,

Premarket Notification for medical devices - PMN or 510(k)

What is a drug interaction

Examples of drug interactions


Antibiotic Definition and classification


Antibiotic resitance and Antibiotic resistance mechanism

Antioxidants food suppliments

Vitamin D Details on FDA cautions on accurate dosage of Vitamin D


What is an antibody? what is monoclonal and polyclonal antibodies?

Terminologies In vaccine Production

Multi stage testing of Virus vaccine production

Testing of vaccines at different stages of production

TESTING FOR ADVENTITIOUS AGENTS CELL PROPERTIES IN VIRAL VACCINE PRODUCTION

Enzyme linked immunosorbent assay ELISA

Raido Immuno assay

http://whoguideline.blogspot.com/2010/04/terminalogy-and-their-explanations.html

Pharmaceutical Aseptic Manufacturing Process Terms , Terminology and Definitions.

http://whoguideline.blogspot.com/2010/02/pharmaceutical-aseptic-manufacturing.html

Here are some articles which will be useful for you in further understanding of aspects of sterile dosage form manufacturing and regulatory affairs and good manufacturing practice in

pharmaceutical industry

Pharmaceutical Validation

Types of validations in pharmaceutical manufacturing


Requirements of documents for validation of sterilisation process

How to investigate OOS out of specification results

Determination of Phenol coefficient of a disinfectant

Sterility testing

Cleen Room Classification

Time limitations in sterile pharmaceuticals processing

Aspects of validation of manufacturing process in sterile pharmaceuticals

Clinical Trials

Controlling Pyrogens in injectable dosage forms

Media fill run process simulation aspects Validation of Aseptic Process and Sterilisation

New Drug Application (NDA) how to make a New Drug Application (NDA) to US FDA

Abbreviated New Drug Application (ANDA) What is ANDA , detaied information about ANDA preparation and submission to US FDA

How to make Investigational New Drug (IND) Application to US FDA

Drug applications submission to us fda Over the counter Drugs OTC drugs

BIOAVAILABILITY AND BIOEQUIVALENCE REQUIREMENTS

Electronic record in pharmaceutical manufacturing industry

Good manufacturing practice in pharmaceutical industry

Pharmaceutical industry pharmaceutical companies and FDA latest updates

Here is an interesting article on world wide pharmaceutical industry and making a carrier in one of pharmaceutical companies article on Pharmaceutical Industry pharmaceutical industry

Find a Job in Pharmaceutical Company
To Find Pharmaceutical jobs and make a Pharmaceutical careers see here pharmaceutical companies
Here are some interesting articles on Quality assurance systems for pharmaceutical company

1.Quality assurance in pharma industry

2.Quality by designe concept for pharmaceutical industry

3.Quality by designe concept in pharmaceutical industryan explanation

No comments:

Posted by: Martin

How to sucessfuly activate and receive our articles on pharmaceuticals by E-Mail

Dear readers if you wish to receive our articles on pharmaceutical automatically into your email Inbox , as and when we write a new article over this website, then follow these 3 simple steps.


1.You should write your Email ID in the box provided and push the subscribe butten


2.Enter the text code that we show you in a small new browser window after you enter your email ID.

3.Log in to your email and Cheke our verification email sent by "FEEDBURNER" , there you should verify the link we send you by email.




Enter your email address get our articles by email whenever this website is updated





Delivered by FeedBurner



Join the list of our readers from Universities ,Research and Development centers Pharmaceutical Companies from all over the world.











Pharma Research Regulatory Guidelines Website
Texas Dallas, TX 75211 US
Email: editor@pharmacistspharmajournal.org Website: http://pharmacistspharmajournal.org/
Copyright © 2008-2015 all rights reserve www.pharmacistspharmajournal.org